Rilpivirine, sold under the brand name Edurant among others, is a medication, developed by Tibotec, used for the treatment of HIV/AIDS. It is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs such as efavirenz.
{{Infobox drug | Verifiedfields = changed | Watchedfields = changed | verifiedrevid = 417509820 | image = Rilpivirine.svg | image_class = skin-invert-image | width = 180 | alt = | image2 = Rilpivirine 3D 2zd1.png | image_class2 = bg-transparent | alt2 =
| tradename = Edurant, Rekambys, others | Drugs.com = | MedlinePlus = a611037 | DailyMedID = Rilpivirine | pregnancy_AU = B1 | pregnancy_category = | routes_of_administration = By mouth, intramuscular | ATC_prefix = J05 | ATC_suffix = AG05 | ATC_supplemental = combinations:
via Wikipedia infobox
via PubMed
Discovered by embedding cosine similarity (sentence-transformers MiniLM, 384-dim).